Skip to content
Page last checked: 14th March 2023
Last updated: 25th January 2023


19th September: Scholar Rock announced the completion of patient enrolment for the SAPPHIRE Trial.


25th January (updated Sept 2023): Trial sites announced for the UK:

Trial Centre Current status / Contact Consultant
Leeds Activated Dr. Childs
Oxford Activated Dr. Servais
Great Ormond Street Activated Dr. Baranello


20th September: Scholar announced the opening of the initial European clinical trial sites for the phase 3 SAPPHIRE study in Spain, with additional sites to be announced.

Read the community update >


2nd December: Scholar Rock announced the design of this Phase 3 trial.

Read the community update >